Deutsch
English
Español
Français
Italiano
Русский

MTS Europe - A company of Tissue Regeneration Technologies, LLC - U.S.A.

dermagold100 - first shockwave therapy system approved for skin lesions MTS Europe GmbH and its partner, Tissue Regeneration Technologies, LLC. (TRT), are pioneers in the field of tissue regeneration.  This partnership enables us to reach new milestones in our exploration of novel treatment methods in the field of dermatology. The Dermagold revolutionizes the treatment of chronic wounds and skin lesions by utilizing the biological effect of shock waves.  The full potential of shock wave therapy is to date unknown, but MTS and TRT are on the cutting edge of research and development in this exciting field.

News Meet us at : Baden-Baden, 30 April-03 May 2009 57. Jahrestagung der Vereinigung Süddeutscher Orthopäden e.V. Sorrento, 01-04 April 2009 12th International Congress of the ISMST Dubai, 26-29 January 2009 Arab Health 2009 German Pavilion - booth # Zabeel Hall, ZE05 Düsseldorf, 19-22 November 2008 Medica, booth 13/E60 Berlin, 22-25 October 2008 Deutscher Kongress für Orthopädie und Unfallchirurgie, Stand 15.1/34

 
 

Home Company Products Technology Therapy Services

Company Career

Dermatology
dermagold Orthopaedics
orthowave 100 orthowave 180C orthowave 280 Urology
lithowave 360CS lithogold Veterinary
vetwave 140

Imprint Terms & Privacy Contact Login

Customer Service Investor